INSTIL BIO INC (TIL) Forecast, Price Target & Analyst Ratings
NASDAQ:TIL • US45783C2008
8.55 USD
-0.21 (-2.4%)
Last: Mar 5, 2026, 04:30 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INSTIL BIO INC (TIL).
Forecast Snapshot
Consensus Price Target
$53.55
+ 526.32% Upside
Next Earnings Forecast
Release DateMay 11, 2026
PeriodQ4 / 2025
EPS Estimate-$2.05
Revenue Estimate
ChartMill Buy Consensus
77.50%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$53.55
Upside
+ 526.32%
From current price of $8.55 to mean target of $53.55, Based on 8 analyst forecasts
Low
$7.07
Median
$39.78
High
$131.25
Price Target Revisions
1 Month
0.00%
3 Months
-45.17%
Price Target Summary
8 analysts have analysed TIL and the average price target is 53.55 USD. This implies a price increase of 526.32% is expected in the next year compared to the current price of 8.55.
The average price target has been revised downward by 45.17% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
77.50%
TIL was analyzed by 8 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about TIL.
In the previous month the buy percentage consensus was at a similar level.
TIL was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-07 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-09-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-02 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2025-05-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-13 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2025-01-07 | Jefferies | Upgrade | Hold -> Buy |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-04 | JMP Securities | Initiate | Market Perform |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | Baird | Reiterate | Outperform -> Outperform |
| 2024-09-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-13 | Baird | Maintains | Outperform -> Outperform |
| 2024-09-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | Baird | Maintains | Outperform -> Outperform |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-12 | Jefferies | Downgrade | Buy -> Hold |
| 2024-03-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 11, 2026
PeriodQ4 / 2025
EPS Estimate-$2.05
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q-12.47%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
29.61%
Next Earnings Summary
TIL is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -2.05 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 140K | 34.845K -100.00% | 336.663K | 54.338M | 156.85M 188.66% | 280.28M 78.69% | 410.77M 46.56% | 514.29M 25.20% | ||||||||
| EBITDA YoY % growth | -6.57M | -33.38M -408.07% | -126.249M -357.79% | -192.941M -29.11% | -90.691M 58.32% | -64.939M 35.08% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -6.59M | -33.64M -410.47% | -146.713M -362.43% | -218.288M -30.68% | -166.144M 57.20% | -84.607M 34.48% | -84.218M -47.75% | -34.766M 58.72% | -86.759M -149.55% | -99.485M -14.67% | -78.881M 20.71% | 3.636M 104.61% | 102.41M 2,716.56% | 206.65M 101.79% | 287.55M 39.15% | |
| Operating Margin | N/A | -24,028.57% | -421,044.20% | -64,838.65% | N/A | N/A | N/A | N/A | N/A | N/A | -145.17% | 2.32% | 36.54% | 50.31% | 55.91% | |
| EPS YoY % growth | N/A | N/A | -27.42 | -33.46 8.28% | -25.10 22.61% | -12.85 52.52% | -11.63 -2.09% | -5.58 51.99% | -8.36 -49.80% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.05 -12.47% | -1.31 69.61% | -1.23 62.07% | -1.20 40.37% | -3.69 -80.26% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.503M -26.42% | -9.178M 36.61% | -8.644M 32.99% | -8.483M 43.53% | -28.05M -93.41% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
8.17%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
INSTIL BIO INC / TIL Forecast FAQ
What is the price target for TIL stock?
8 analysts have analysed TIL and the average price target is 53.55 USD. This implies a price increase of 526.32% is expected in the next year compared to the current price of 8.55.
What is the next earnings date for TIL stock?
INSTIL BIO INC (TIL) will report earnings on 2026-05-11.
Can you provide the consensus estimates for INSTIL BIO INC next earnings?
The consensus EPS estimate for the next earnings of INSTIL BIO INC (TIL) is -2.05 USD and the consensus revenue estimate is 0 USD.
Can you provide the analyst count for INSTIL BIO INC stock?
The number of analysts covering INSTIL BIO INC (TIL) is 8.